4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide

C19H24BrN3O2 — CID 9371020

IUPAC4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide
SMILESCC1(C)[C@@H]2CC[C@@]1(C)/C(=N/NC(=O)CNC(=O)c1ccc(Br)cc1)C2
InChIInChI=1S/C19H24BrN3O2/c1-18(2)13-8-9-19(18,3)15(10-13)22-23-16(24)11-21-17(25)12-4-6-14(20)7-5-12/h4-7,13H,8-11H2,1-3H3,(H,21,25)(H,23,24)/b22-15+/t13-,19+/m1/s1
InChIKeyRNARNHJPMSVTJD-QMWASXFSSA-N
MW406.32 g/mol
LogP3.50
Rot. Bonds4

About 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide

4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide (PubChem CID 9371020) has the molecular formula C19H24BrN3O2 and a molecular weight of 406.32 g/mol. Its IUPAC name is 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide.

Molecular Properties

Compound Name4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide
PubChem CID9371020
Molecular FormulaC19H24BrN3O2
Molecular Weight406.32 g/mol
Exact Mass405.11
IUPAC Name4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide
SMILESCC1(C)[C@@H]2CC[C@@]1(C)/C(=N/NC(=O)CNC(=O)c1ccc(Br)cc1)C2
InChIInChI=1S/C19H24BrN3O2/c1-18(2)13-8-9-19(18,3)15(10-13)22-23-16(24)11-21-17(25)12-4-6-14(20)7-5-12/h4-7,13H,8-11H2,1-3H3,(H,21,25)(H,23,24)/b22-15+/t13-,19+/m1/s1
InChIKeyRNARNHJPMSVTJD-QMWASXFSSA-N
XLogP3.50
TPSA70.56 Ų
H-Bond Donors2
H-Bond Acceptors3
Rotatable Bonds4
Heavy Atoms25
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500406.32
LogP ≤ 53.50
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 103

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide?
The IUPAC name of 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide (CID 9371020) is 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide.
What is the SMILES notation for 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide?
The canonical SMILES for 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide is CC1(C)[C@@H]2CC[C@@]1(C)/C(=N/NC(=O)CNC(=O)c1ccc(Br)cc1)C2.
What is the InChIKey of 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide?
The InChIKey is RNARNHJPMSVTJD-QMWASXFSSA-N. The full InChI is InChI=1S/C19H24BrN3O2/c1-18(2)13-8-9-19(18,3)15(10-13)22-23-16(24)11-21-17(25)12-4-6-14(20)7-5-12/h4-7,13H,8-11H2,1-3H3,(H,21,25)(H,23,24)/b22-15+/t13-,19+/m1/s1.
What are the key properties of 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide?
4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide has a molecular weight of 406.32 g/mol, XLogP of 3.50, 4 rotatable bonds, 2 hydrogen bond donors, and 3 hydrogen bond acceptors.
Where does this data come from?
All data for 4-bromo-N-[2-oxo-2-[(2E)-2-[(1R,4R)-1,7,7-trimethyl-2-bicyclo[2.2.1]heptanylidene]hydrazinyl]ethyl]benzamide is sourced from PubChem (CID 9371020), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).